Product NewsMRC Technology Highlights Presentation of Data for Lambrolizumab Developed Using its Humanization Technology
Product NewsNaurex Announces Initiation of Phase I Trial for Second-Generation NOVEL ANTIDEPRESSANT AGENT NRX-1074
Product NewsAlmac Discovery Announces Licensing of ALM201 to Shin Poong for Development and Marketing in South Korea
Product NewsGenticel Secures EUR 18.2 million (USD 23.7 million) in Capital Funding to Develop Vaccines for Patients Infected with HPV
Product NewsAddex Announces Issuance of a Broad European Composition of Matter Patent for Dipraglurant
Product NewsNew Data from TIMI Study Group to Be Presented at American College of Cardiology Scientific Session Show Prognostic Value of High-Precision Cardiac Troponin Monitoring
Product NewsMersana Therapeutics Presents Positive Preclinical Data on Next-Generation Antibody-Drug Conjugate Technology at AACR 2013
Product NewsBio-Rad Launch New Bio-Plex Pro™ RBM Kidney Toxicity Panels for the Early Detection and Characterization of Kidney Toxicity and Injury During Drug Development
Product NewsAddex Dipraglurant Reduces Motor Abnormalities in a Preclinical Model Relevant for Several Rare Types of Dystonia
Product NewsApitope Completes Recruitment into its Clinical Trial of ATX-MS-1467 in Multiple Sclerosis
Product NewsSkuldtech Identifies New Predictive Markers for Pancreatic Cancer Survival Resulting From its Proprietary Technology Platform
Product NewsDomainex Researchers Identify Small-Molecule Inhibitors of TBK1/IKKepsilon Affecting IL-17 Signaling
Product NewsAddex Reports Top-line Data from a Successful Phase 2a Clinical Study with ADX71149 in Schizophrenia Patients
Product NewsEMD Millipore to Showcase Drug Bioavailability Solutions and Expanded Chemical and Reagent Portfolio at AAPS
